Start Date
April 30, 2010
Primary Completion Date
January 31, 2011
Study Completion Date
June 30, 2011
LINjeta U-100 Insulin
LINjeta U-100 Insulin will be used per the subjects normal insulin carbohydrate and insulin sensitivity factors
Humalog U-100
Normal short acting insulin used in participants daily life including carbohydrate ratios and insulin sensitivity factors
University of Colorado Denver School of Medicine Barbara Davis Center, Denver
Stanford University School of Medicine, Stanford
Collaborators (1)
Biodel
INDUSTRY
University of Colorado, Denver
OTHER
Stanford University
OTHER